Type 2 Diabetes Study

Now Enrolling Adults Ages 18 to 75

Now Enrolling

About this research study

While diet and exercise can help manage the symptoms of type 2 diabetes (T2D), there is no cure. People with T2D either resist the effects of insulin, or their bodies don’t produce enough of the hormone to maintain normal levels of glucose. Velocity is now conducting a clinical trial for an investigational diabetes medication.

Eligible participants...

  • Must be age 18 to 75
  • Must have a diagnosis of type 2 diabetes mellitus for at least 180 days
  • Must be on a stable daily dose of metformin with or without an SGLT2 inhibitor for at least 90 days
  • Must have a BMI of 23 kg/m2 or greater
  • Will receive compensation for study-related time

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Abilene, Texas • Velocity Clinical Research

1665 Antilley Rd., Ste. 180, Abilene, TX 79606
Phone: (325) 400-2314

Austin, Texas • Velocity Clinical Research

12515-2 Research Blvd, Suite 225, Austin, TX 78759
Phone: (512) 506-8287

Chula Vista, California • Velocity Clinical Research

754 Medical Center Ct, Suite 202, Chula Vista, CA 91911
Phone: (619) 955-5246

Cincinnati (Blue Ash), Ohio • Velocity Clinical Research

4260 Glendale Milford Road, Suite 201, Cincinnati, OH 45242
Phone: (513) 769-2767

Cincinnati (Springdale), Ohio • Velocity Clinical Research

375 Glensprings Dr 2nd Floor, Cincinnati, OH 45246
Phone: (513) 671-8080

San Diego (La Mesa), California • Velocity Clinical Research

5565 Grossmont Center Dr Building 2, Suite 1, La Mesa, CA 91942
Phone: (619) 567-1550

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy